{"id":"https://openalex.org/W4404583166","doi":"https://doi.org/10.1200/go.24.00122","title":"Low-Dose Anti-PD(L)1 for the Treatment of Solid Malignancies","display_name":"Low-Dose Anti-PD(L)1 for the Treatment of Solid Malignancies","publication_year":2024,"publication_date":"2024-11-01","ids":{"openalex":"https://openalex.org/W4404583166","doi":"https://doi.org/10.1200/go.24.00122","pmid":"https://pubmed.ncbi.nlm.nih.gov/39571116"},"language":"en","primary_location":{"id":"doi:10.1200/go.24.00122","doi":"https://doi.org/10.1200/go.24.00122","is_oa":true,"landing_page_url":"https://doi.org/10.1200/go.24.00122","pdf_url":null,"source":{"id":"https://openalex.org/S4210209558","display_name":"JCO Global Oncology","issn_l":"2687-8941","issn":["2687-8941"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Global Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1200/go.24.00122","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108840992","display_name":"Iza Andrade de A. Souza","orcid":"https://orcid.org/0009-0007-2573-8414","observed_orcids":["https://orcid.org/0009-0007-2573-8414"]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Iza Andrade de A. Souza","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":"https://orcid.org/0009-0007-2573-8414","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046404501","display_name":"Beatriz de Menezes Dobbert","orcid":"https://orcid.org/0000-0001-8111-3311","observed_orcids":["https://orcid.org/0000-0001-8111-3311"]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Beatriz de M. Dobbert","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":"https://orcid.org/0000-0001-8111-3311","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104124501","display_name":"Barbara Garcia S\u00e3o Jos\u00e9","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Barbara G. Sao Jose","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003494004","display_name":"Jo\u00e3o Pedro Homse Netto","orcid":"https://orcid.org/0000-0002-8556-7131","observed_orcids":["https://orcid.org/0000-0002-8556-7131"]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Joao Pedro Homse-Netto","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052150533","display_name":"Larissa Lazzarini Furlan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Larissa L. Furlan","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Maira S. Abreu","orcid":"https://orcid.org/0009-0009-0747-3664","observed_orcids":["https://orcid.org/0009-0009-0747-3664"]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Maira S. Abreu","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":"https://orcid.org/0009-0009-0747-3664","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Camila Ferrari","orcid":"https://orcid.org/0009-0004-1668-3210","observed_orcids":["https://orcid.org/0009-0004-1668-3210"]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Camila Ferrari","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":"https://orcid.org/0009-0004-1668-3210","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044218122","display_name":"Bruno Cezar de Mendon\u00e7a Uch\u00f4a","orcid":"https://orcid.org/0009-0009-5146-3199","observed_orcids":["https://orcid.org/0009-0009-5146-3199"]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Bruno Uchoa","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":"https://orcid.org/0009-0009-5146-3199","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kathia Abdallah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Kathia Abdallah","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114737640","display_name":"Stephano N. Lucio","orcid":"https://orcid.org/0000-0003-3798-2207","observed_orcids":["https://orcid.org/0000-0003-3798-2207"]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Stephano N. Lucio","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":"https://orcid.org/0000-0003-3798-2207","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022212520","display_name":"Joao A. Soler","orcid":"https://orcid.org/0009-0001-7301-4353","observed_orcids":["https://orcid.org/0009-0001-7301-4353"]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Joao A. Soler","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":"https://orcid.org/0009-0001-7301-4353","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024558624","display_name":"Fabio Leite Couto Fernandez","orcid":"https://orcid.org/0000-0002-3447-6694","observed_orcids":["https://orcid.org/0000-0002-3447-6694"]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Fabio L.C. Fernandez","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000869076","display_name":"Luiza Silva Ferreira","orcid":"https://orcid.org/0009-0004-7840-4790","observed_orcids":["https://orcid.org/0009-0004-7840-4790"]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Luiza Ferreira","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":"https://orcid.org/0009-0004-7840-4790","affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063486775","display_name":"Jo\u00e3o Daniel Guedes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Joao D. Guedes","raw_affiliation_strings":["Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073462876","display_name":"Aline Fusco Fares","orcid":"https://orcid.org/0000-0002-7730-9810","observed_orcids":["https://orcid.org/0000-0002-7730-9810"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR","CA"],"is_corresponding":false,"raw_author_name":"Aline F. Fares","raw_affiliation_strings":["Department of Medical Oncology, BC Cancer Abbotsford, Abbotsford, Canada","Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-7730-9810","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, BC Cancer Abbotsford, Abbotsford, Canada","institution_ids":["https://openalex.org/I1289530486"]},{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091333362","display_name":"Daniel Vilarim Ara\u00fajo","orcid":"https://orcid.org/0000-0002-7013-5408","observed_orcids":["https://orcid.org/0000-0002-7013-5408"]},"institutions":[{"id":"https://openalex.org/I1289530486","display_name":"BC Cancer Agency","ror":"https://ror.org/03sfybe47","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1289530486"]},{"id":"https://openalex.org/I4210155407","display_name":"Hospital de Base","ror":"https://ror.org/04qbxyj42","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I4210155407"]}],"countries":["BR","CA"],"is_corresponding":false,"raw_author_name":"Daniel V. Araujo","raw_affiliation_strings":["Department of Medical Oncology, BC Cancer Abbotsford, Abbotsford, Canada","Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil"],"raw_orcid":"https://orcid.org/0000-0002-7013-5408","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, BC Cancer Abbotsford, Abbotsford, Canada","institution_ids":["https://openalex.org/I1289530486"]},{"raw_affiliation_string":"Division of Medical Oncology, Hospital de Base\u2014FUNFARME, S\u00e3o Jos\u00e9 do Rio Preto, Brazil","institution_ids":["https://openalex.org/I4210155407"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2472,"currency":"USD","value_usd":2472},"apc_paid":{"value":2472,"currency":"USD","value_usd":2472},"fwci":1.4546,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.83776615,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"10","issue":"10","first_page":"e2400122","last_page":"e2400122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9480000138282776},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6399999856948853},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8209999799728394},{"id":"https://openalex.org/keywords/dose-reduction","display_name":"dose reduction","score":0.5220000147819519},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.625},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.7559999823570251},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9890000224113464},{"id":"https://openalex.org/keywords/treatment-accessibility","display_name":"treatment accessibility","score":0.46000000834465027},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8800029754638672},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7408521771430969},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5827280282974243},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5170682072639465},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3992266356945038},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.20568546652793884},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.19114580750465393},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001938","descriptor_name":"Brazil","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1200/go.24.00122","doi":"https://doi.org/10.1200/go.24.00122","is_oa":true,"landing_page_url":"https://doi.org/10.1200/go.24.00122","pdf_url":null,"source":{"id":"https://openalex.org/S4210209558","display_name":"JCO Global Oncology","issn_l":"2687-8941","issn":["2687-8941"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Global Oncology","raw_type":"journal-article"},{"id":"pmid:39571116","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39571116","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO global oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:b1d064690de94f7a891e06ea352b2951","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b1d064690de94f7a891e06ea352b2951","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JCO Global Oncology, Iss 10 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1200/go.24.00122","doi":"https://doi.org/10.1200/go.24.00122","is_oa":true,"landing_page_url":"https://doi.org/10.1200/go.24.00122","pdf_url":null,"source":{"id":"https://openalex.org/S4210209558","display_name":"JCO Global Oncology","issn_l":"2687-8941","issn":["2687-8941"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCO Global Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1990675339","https://openalex.org/W2010121426","https://openalex.org/W2093274439","https://openalex.org/W2148706732","https://openalex.org/W2150048477","https://openalex.org/W2222086386","https://openalex.org/W2585781742","https://openalex.org/W2590497374","https://openalex.org/W2943781197","https://openalex.org/W2944434778","https://openalex.org/W2965322165","https://openalex.org/W3033788027","https://openalex.org/W3120123676","https://openalex.org/W3131433923","https://openalex.org/W3200608261","https://openalex.org/W3207044389","https://openalex.org/W3207460645","https://openalex.org/W4213455475","https://openalex.org/W4233656512","https://openalex.org/W4281658553","https://openalex.org/W4298007568","https://openalex.org/W4302362490","https://openalex.org/W4306921237","https://openalex.org/W4308571877","https://openalex.org/W4385567914","https://openalex.org/W4386476688","https://openalex.org/W4389091940"],"related_works":["https://openalex.org/W4379281264","https://openalex.org/W4411114799","https://openalex.org/W4406202673","https://openalex.org/W7223102634","https://openalex.org/W4281658553","https://openalex.org/W4410815040","https://openalex.org/W4411533976","https://openalex.org/W4415940446","https://openalex.org/W4280570851","https://openalex.org/W7160831405"],"abstract_inverted_index":{"PURPOSE":[0],"Mounting":[1],"data":[2],"suggest":[3],"that":[4],"lower":[5],"doses":[6,16],"of":[7,20,27,46,142,157,185],"anti-PD(L)1":[8,37,53,258],"agents":[9,54],"can":[10],"be":[11,260],"as":[12,14,66],"efficacious":[13],"label-approved":[15,80],"at":[17,58],"a":[18,175,182],"fraction":[19],"its":[21],"cost.":[22],"We":[23],"compare":[24],"the":[25,44,70,74,79,128,143],"outcomes":[26,45],"patients":[28,47,109,144,228,250],"treated":[29,51,146,251],"with":[30,34,48,52,114,119,147,227,252],"low-dose":[31],"(LD)":[32],"and":[33,95,116,134,151,166,214,233,247,254],"conventional-dose":[35],"(CD)":[36],"agents.":[38,121],"METHODS":[39],"This":[40],"observational":[41],"study":[42,240],"evaluates":[43],"solid":[49],"malignancies":[50],"(LD":[55],"or":[56],"CD)":[57,133],"Hospital":[59],"de":[60],"Base,":[61],"Brazil.":[62],"Patients":[63],"were":[64,99,110,127,145,189,236],"classified":[65],"receiving":[67,229],"LD":[68,115,150,165,194,253,257],"if":[69],"dose":[71,156],"administered":[72],"in":[73,164,171,197,244,270],"first":[75],"cycle":[76],"was":[77,159,231],"below":[78],"dose.":[81],"Efficacy":[82],"outcomes,":[83],"including":[84],"best":[85],"clinical":[86,91],"overall":[87,96],"response":[88],"rate":[89],"(cORR),":[90],"progression-free":[92],"survival":[93,97],"(cPFS),":[94],"(OS),":[98],"evaluated.":[100],"RESULTS":[101],"From":[102],"January":[103],"2020":[104],"to":[105,263],"May":[106],"2023,":[107],"71":[108],"included:":[111],"49":[112],"(69%)":[113],"22":[117],"(31%)":[118],"CD":[120,172,196,255],"The":[122,154],"most":[123],"frequent":[124],"tumor":[125],"sites":[126],"lung":[129],"(41%":[130],"LD,":[131,138],"22.9%":[132],"skin":[135],"(melanoma;":[136],"24.6%":[137],"50%":[139],"CD).":[140,153],"Most":[141],"pembrolizumab":[148,158,230],"(65%":[149],"72%":[152],"mean":[155],"95.3":[160],"mg":[161,168],"(1.5":[162],"mg/kg)":[163,170],"168.7":[167],"(2.12":[169],"groups,":[173],"once":[174],"day,":[176],"q21d":[177],"(every":[178],"21":[179],"days).":[180],"After":[181],"median":[183],"follow-up":[184],"10.9":[186],"months,":[187],"there":[188],"no":[190,242],"significant":[191],"differences":[192,243],"between":[193,249],"versus":[195],"cORR":[198],"(38.1%":[199],"v":[200,208,218],"35.2%,":[201],"P":[202,211,221],"=":[203,212,222],".31),":[204],"cPFS":[205],"(5.3":[206],"m":[207,217],"7":[209],"m,":[210],".36),":[213],"OS":[215,248],"(12.8":[216],"not":[219],"reached,":[220],".17).":[223],"A":[224],"subgroup":[225],"analysis":[226],"performed,":[232],"similar":[234],"results":[235],"obtained.":[237],"CONCLUSION":[238],"Our":[239],"found":[241],"cORR,":[245],"cPFS,":[246],"anti-PD(L)1.":[256],"could":[259],"an":[261],"alternative":[262],"promote":[264],"accessibility,":[265],"which":[266],"warrants":[267],"further":[268],"investigation":[269],"randomized":[271],"trials.":[272]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2024-11-22T00:00:00"}